HiberCell

HiberCell

Biotechnology Research 619 West 54th Street 27 employees
Employees
27
Contacts
4
Emails
4
Phones
3

HiberCell Overview

Headquarters
619 West 54th Street
Phone Number
Available in AeroLeads
Website
hibercell.com
Industry
Biotechnology Research
Employees
27
Funding
67.4M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About HiberCell

HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti-tumor immunity. We believe that therapeutic modulation of these mechanisms allows us to address tumor metastasis, treatment resistance, and cancer relapse; all significant drivers of cancer-related deaths. Our product candidates HC-5404 and HC-7366, both completing Phase 1a clinical trials, target the stress response kinases PERK and GCN2, respectively, while our product candidate odetiglucan, currently in Phase 2 clinical development, modulates the anti-tumor innate immune response.

HiberCell Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

HiberCell Org Chart

Sample employees and titles
Name Title Contact
Michael Danielson Executive Director Head of Cmc
Email Phone
Kathryn Bieging-Rolett, Phd Senior Scientist at Hibercell
Email
Pulkit Gupta, Phd Executive Director, Lilly Ventures
Email Phone
Michele Gargano
Email Phone

Employees by Management Level

Individual contributor 4 profiles
Senior / Lead 2 profiles
VP / Head 1 profile
Director 1 profile
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 2
Healthcare 1 1 0

Compare Similar Companies to HiberCell